The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade

Patrizia Sini, Jeanette M. Wood|Clinical Cancer Research|2005

Cited by 86